Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Urology ; 178: 147-150, 2023 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-37178876

RESUMEN

Testosterone and dihydrotestosterone are significant drivers of male external genital development, and therefore teratogens that alter these hormone profiles have been hypothesized to cause aberrations in development. Here, we present the first case report of genitalia anomalies after prenatal exposure to spironolactone and dutasteride through 8-weeks of gestation. The patient was born with abnormal male external genitalia which was surgically managed. Long-term outcomes such as gender identity, sexual function, hormonal maturation through puberty, and fertility remain unknown. These numerous considerations necessitate multi-disciplinary management with close follow-up to address sexual, psychological, and anatomic concerns.


Asunto(s)
Colestenona 5 alfa-Reductasa , Trastornos del Desarrollo Sexual , Embarazo , Humanos , Masculino , Femenino , Identidad de Género , 3-Oxo-5-alfa-Esteroide 4-Deshidrogenasa , Testosterona/uso terapéutico , Dihidrotestosterona
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA